- Home
- ERAS vs CION Comparison
ERAS vs CION Comparison
Compare ERAS & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- CION
- Stock Information
- Founded
- ERAS 2018
- CION 2011
- Country
- ERAS United States
- CION United States
- Employees
- ERAS N/A
- CION N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- CION Finance/Investors Services
- Sector
- ERAS Health Care
- CION Finance
- Exchange
- ERAS Nasdaq
- CION Nasdaq
- Market Cap
- ERAS 723.8M
- CION 626.1M
- IPO Year
- ERAS 2021
- CION N/A
- Fundamental
- Price
- ERAS $2.47
- CION $11.65
- Analyst Decision
- ERAS Strong Buy
- CION Hold
- Analyst Count
- ERAS 5
- CION 2
- Target Price
- ERAS $5.90
- CION $12.25
- AVG Volume (30 Days)
- ERAS 1.2M
- CION 250.6K
- Earning Date
- ERAS 11-12-2024
- CION 11-07-2024
- Dividend Yield
- ERAS N/A
- CION 12.18%
- EPS Growth
- ERAS N/A
- CION 50.69
- EPS
- ERAS N/A
- CION 1.48
- Revenue
- ERAS N/A
- CION $254,537,000.00
- Revenue This Year
- ERAS N/A
- CION $0.86
- Revenue Next Year
- ERAS N/A
- CION N/A
- P/E Ratio
- ERAS N/A
- CION $7.97
- Revenue Growth
- ERAS N/A
- CION 3.26
- 52 Week Low
- ERAS $1.64
- CION $10.52
- 52 Week High
- ERAS $3.45
- CION $12.69
- Technical
- Relative Strength Index (RSI)
- ERAS 42.73
- CION 56.70
- Support Level
- ERAS $2.51
- CION $11.33
- Resistance Level
- ERAS $2.68
- CION $12.00
- Average True Range (ATR)
- ERAS 0.21
- CION 0.16
- MACD
- ERAS -0.04
- CION 0.04
- Stochastic Oscillator
- ERAS 14.56
- CION 72.39
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies.